Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Alzamend Neuro, Inc. (ALZN) had Normalized Income after Taxes of $-4.51M for the most recently reported fiscal year, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-5.11M |
|
-- |
|
-- |
|
$4.50M |
|
$-4.50M |
|
$-0.02M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
$-4.51M |
|
|
Normalized Income after Taxes |
$-4.51M |
$-4.50M |
|
$-4.45M |
|
0.45M |
|
0.45M |
|
$-11.32 |
|
$-11.32 |
|
| Balance Sheet Financials | |
$4.18M |
|
$0.43M |
|
$0.43M |
|
$4.60M |
|
$0.63M |
|
-- |
|
-- |
|
$0.63M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
0.78M |
|
| Cash Flow Statement Financials | |
$-6.57M |
|
$-0.30M |
|
$10.44M |
|
$0.38M |
|
$3.95M |
|
$3.57M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-113.78% |
|
-113.78% |
|
-98.09% |
|
-113.78% |
|
$5.10 |
|
$-15.24 |
|
$-14.57 |
|